Related Experiment Videos
Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis
J Danesh1, P Whincup, M Walker
1Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford OX2 6HE.
Insights
This study found no strong link between coronary heart disease and chronic Chlamydia pneumoniae infection markers. A meta-analysis confirmed no significant association, suggesting other factors are more critical for heart disease risk.
Area of Science:
- Cardiology
- Infectious Diseases
- Epidemiology
Background:
- Coronary heart disease (CHD) is a leading cause of mortality globally.
- Chronic Chlamydia pneumoniae infection has been investigated as a potential risk factor for CHD.
- Understanding the association is crucial for public health strategies and preventative measures.
Purpose of the Study:
- To investigate the relationship between serum markers of chronic Chlamydia pneumoniae infection and the incidence of coronary heart disease.
- To conduct a meta-analysis of existing prospective studies to consolidate evidence on this association.
Main Methods:
- A nested case-control analysis was performed within a prospective cohort study of British men aged 40-59.
- Serum IgG antibodies to Chlamydia pneumoniae were measured at baseline.
- Data on fatal and non-fatal coronary heart disease events were collected and analyzed, alongside a meta-analysis of 14 previous studies.
Main Results:
- The study found an initial odds ratio of 1.66 for CHD with high Chlamydia pneumoniae titres, which reduced to 1.22 after adjustments.
- No significant associations were observed between Chlamydia pneumoniae IgG titres and lipid concentrations, blood pressure, or homocysteine levels.
- The aggregate meta-analysis of 3169 cases yielded a combined odds ratio of 1.15 (95% CI 0.97 to 1.36), with no significant heterogeneity.
Conclusions:
- The findings reliably exclude a strong association between Chlamydia pneumoniae IgG titres and incident coronary heart disease.
- While a strong link is unlikely, further research may be needed to explore any potential modest association, particularly in younger populations.
Objective:
To examine the association between coronary heart disease and serum markers of chronic Chlamydia pneumoniae infection.
Design:
"Nested" case-control analysis in a prospective cohort study and an updated meta-analysis of previous relevant studies.
Setting:
General practices in 18 towns in Britain.
Participants:
Of the 5661 men aged 40-59 who provided blood samples during 1978-80, 496 men who died from coronary heart disease or had non-fatal myocardial infarction and 989 men who had not developed coronary heart disease by 1996 were included.
Main Outcome Measures:
IgG serum antibodies to C pneumoniae in baseline samples; details of fatal and non-fatal coronary heart disease from medical records and death certificates.
Results:
200 (40%) of the 496 men with coronary heart disease were in the top third of C pneumoniae titres compared with 329 (33%) of the 989 controls. The corresponding odds ratio for coronary heart disease was 1.66 (95% confidence interval 1.25 to 2.21), which fell to 1.22 (0.82 to 1.82) after adjustment for smoking and indicators of socioeconomic status. No strong associations were observed between C pneumoniae IgG titres and blood lipid concentrations, blood pressure, or plasma homocysteine concentration. In aggregate, the present study and 14 other prospective studies of C pneumoniae IgG titres included 3169 cases, yielding a combined odds ratio of 1. 15 (0.97 to 1.36), with no significant heterogeneity among the separate studies (chi(2)=10.5, df=14; P>0.1).
Conclusion:
This study, together with a meta-analysis of previous prospective studies, reliably excludes the existence of any strong association between C pneumoniae IgG titres and incident coronary heart disease. Further studies are required, however, to confirm or refute any modest association that may exist, particularly at younger ages.